Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-19-019885

Director bought 2,000 shares at $6.98 ($13,958)

From the SEC's structured data for this filing

Trades in this filing

Hochman David P · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-03-15 Purchase : show line 1 in the form +2,000 $6.98 $13,958 7,000 I
Open-market purchases · 2,000 sh · avg $6.98 · $13,958
Loading xslF345X03/doc4.xml…